Maintenance Treatment of Multiple Myeloma (MM) After Autologous Peripheral Blood Transplant (PBSCT) Using Polyethylene Glycol alpha2B Interpheron (PEG-INTRON)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Adrián Alegre Amor, Physician Doctor
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Principal Investigator - Jesús San Miguel, Physician Doctor
Hospital Clínico Universitario. Salamanca, Spain
Principal Investigator - José García Laraña, Physician
Hospital Ramón y Cajal. Madrid, Spain
Principal Investigator - Juan José Lahuerta, Physician Doctor
Hospital 12 de Octubre. Madrid, Spain
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitario de la Princesa
Madrid, Madrid, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2002
- Primary completion
- 31 Mar 2012
- Completion
- 31 Mar 2012
- Last update posted
- 31 Mar 2011
- Registered enrollment
- 33
- Registry id
- NCT01325896
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.